Jun.-Prof. Adrian Tibor Press

Jun.-Prof. Dr. Adrian Press
Jun.-Prof. Dr. Adrian Press
Image: Jun.-Prof. Dr. Adrian Press

University Hospital Jena
Clinic for Anaesthesiology and Intensive Care Medicine
Am Klinikum 1
07747 Jena
Phone: + 49 3641 9 323 139
Fax: + 49 3641 9 323 102
adrian.press@med.uni-jena.de
HomepageExternal link

Functions

Junior Professor
Head of the Research Group "Nanophysiology of Life-threatening Infections"

Research

  • Nanomedicine
  • Molecular medicine
  • Life-threatening infections

Publications (selected 5 most recent)

  1. Hoff J, Xiong L, Kammann T, Neugebauer S, Micheel JM, Gaßler N, Bauer M, Press AT. RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. Cell Death Dis.2023;14(4):275. DOI: https://doi.org/10.1038/s41419-023-05794-0External link
  2. Press AT, Babic P, Hoffmann B, Müller T, Foo W, Hauswald W, Benecke J, Beretta M, Cseresnyes Z, Hoeppner S, Nischang I, Coldewey SM, Gräler MH, Bauer R, Gonnert F, Gaßler N, Wetzker R, Figge MT, Schubert US, Bauer M, Targeted delivery of a phosphoinositide 3-kinase γ inhibitor to restore organ function in sepsis through dye-functionalized lipid nanocarriers, EMBO Molecular Medicine, 2021, 13(10):e14436 DOI: https://doi.org/10.15252/emmm.202114436External link
  3. Muljajew I, Husche S, Ramoji A, Cseresnyes Z, Hoeppener S, Nischang I, Foo Wanling, Popp J, Figge MT, Weber C, Bauer M, Schubert US*, Press AT*, Stealth Effect of Short Polyoxazolines in Graft Copolymers: Minor Changes of Backbone End Group Determine Liver Cell-Type Specificity, ACS Nano, 2021, 15(7): 12298–12313, *co-first author/ correspondence,  DOI: https://doi.org/10.1021/acsnano.1c04213External link
  4. Foo W, Wiede A, Bierwirth S, Heintzmann R, Press AT*, Hauswald W*, *shared senior authorship. Automated multicolor mesoscopic imaging for the 3-dimensional reconstruction of fluorescent biomarker distribution in large tissue specimens. Biomedical Optics Express 2022, 13(7): 3723-3742. DOI: https://doi.org/10.1364/BOE.455215External link
  5.  Sommerfeld O, Anna Medyukhina A, Neugebauer S, Ghait M, Ulferts S, Lupp A, König R, Wetzker R, Schulz S, Figge MT, Bauer M, Press AT, Targeting Complement C5a receptor 1 is a theranostic target for the treatment of immunosuppression in sepsis, Molecular Therapy, 2020, 29(1):338-346. DOI: https://doi.org/10.1016/j.ymthe.2020.09.008External link